Home Cart Sign in  
Chemical Structure| 857531-00-1 Chemical Structure| 857531-00-1

Structure of AT7867
CAS No.: 857531-00-1

Chemical Structure| 857531-00-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AT7867 is a potent ATP-competitive inhibitor of Akt1/2/3 and p70S6K/PKA with IC50 of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively, exhibiting little activity outside the AGC kinase family.

Synonyms: AT7867

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AT7867

CAS No. :857531-00-1
Formula : C20H20ClN3
M.W : 337.85
SMILES Code : ClC1=CC=C(C2(C3=CC=C(C4=CNN=C4)C=C3)CCNCC2)C=C1
Synonyms :
AT7867
MDL No. :MFCD18384971
InChI Key :LZMOSYUFVYJEPY-UHFFFAOYSA-N
Pubchem ID :11175137

Safety of AT7867

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of AT7867

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • Akt3

    Akt3, IC50:47 nM

  • Akt1

    Akt1, IC50:32 nM

  • Akt2

    Akt2, IC50:17 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Colorectal cancer stem-like cells 0-25 µM 24, 48, and 72 h AT7867 induces G2/M phase arrest and cell apoptosis in CSCs. PMC9943616

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice subcutaneous colorectal cancer model Intraperitoneal injection 15 mg/kg and 25 mg/kg every other day for 14 days AT7867 reduced the average tumor volume significantly in the treated groups compared to the control. PMC9943616

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.96mL

0.59mL

0.30mL

14.80mL

2.96mL

1.48mL

29.60mL

5.92mL

2.96mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories